SCHEMBL23960209

SCHEMBL23960209

NC(=O)c1ccc(-c2cc(CCl)ccn2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 2/20 0.49
MKNK1 Q9BUB5 1/20 0.49
KMO O15229 3/20 0.45
LOXL2 Q9Y4K0 3/20 0.44
MAP4K4 O95819 3/20 0.43
CASP1 P29466 4/20 0.41
PDK2 Q15119 1/20 0.39
KMT2A Q03164 1/20 0.38
ABL1 P00519 2/20 0.38
KDR P35968 2/20 0.38
PIK3CD O00329 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
SRC P12931 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38
PI4KB Q9UBF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23931703 0.99 MKNK2 (0.48) MKNK2MKNK1KMOLOXL2MAP4K4
SCHEMBL23931758 0.89 MKNK2 (0.49) MKNK2MKNK1KMOLOXL2MAP4K4
SCHEMBL23931720 0.85 MKNK2 (0.48) MKNK2MKNK1LOXL2MAP4K4ABL1
Hydrochloric Acid SCHEMBL30267091 0.84 MKNK2 (0.47) MKNK2MKNK1LOXL2MAP4K4ABL1
Hydrochloric Acid SCHEMBL23931772 0.84 MKNK2 (0.47) MKNK2MKNK1LOXL2MAP4K4ABL1
SCHEMBL30492056 0.83 MKNK1 (0.43) MKNK2MKNK1KMOLOXL2MAP4K4
SCHEMBL23931722 0.83 MKNK1 (0.43) MKNK2MKNK1KMOLOXL2MAP4K4
Hydrochloric Acid SCHEMBL4427907 0.78 KMO (0.53) KMOLOXL2PIK3CAPIK3CB
SCHEMBL23931796 0.78 MAOB (0.49) CASP1
SCHEMBL30267398 0.78 MAOB (0.49) CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234925-A1 GPR52 MODULATORS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. 2023-07-27 US disclosed
WO-2021216705-A1 GPR52 MODULATORS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234925-A1 GPR52 MODULATORS AND METHODS OF USE GPR52, GPR68, GPR35 MKNK2 2806/4885MKNK1 3584/4885KMO 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.